TEBOTELIMAB
UNII L62556GPXB

Substance Identification & Data

This profile provides standardized clinical and technical data for Tebotelimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) L62556GPXB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2245725-04-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
L62556GPXB
CAS Registry Number
2245725-04-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TEBOTELIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11338
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tebotelimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TEBOTELIMAB

Common Names & Synonyms

MABFRAG HUMAN (FC)MABFRAG HUMANIZED (FAB) ANTI Q15116 (PDCD1_HUMAN)MABFRAG HUMANIZED (FAB) ANTI P18627 (LAG3_HUMAN) (MGD013)
MGD013
MGD-013
MGD013 (PD-1 X LAG-3)
MGD013 DUAL-AFFINITY RE-TARGETING (DART)
TEBOTELIMAB [INN]
TEBOTELIMAB [WHO-DD]